CSc1nnc2c(n1)OC(c1cn(C)c3ccccc13)N(C(C)=O)c1ccccc1-2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?